Scientific Organising Committee
- Annalisa Berzigotti, Switzerland
- Markus Cornberg, Germany
- Dr Alejandro Forner, Spain
- Marco Marzioni, Ancona, Italy
- Philip N. Newsome, United Kingdom
Every year in April, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging come together from around the world to learn about the latest in liver research.Specialists share recent data, present studies and findings, and discuss the hottest topics on liver disease. The annual Congress attracts around 10,000 delegates and 250 media representatives from all over the world making this a truly international networking opportunity!
The International Liver CongressTM 2018 will take place 11-15 April 2018 at the Paris expo Porte de Versailles – Pavillon 7, Paris, France.
Welcome to Paris to The International Liver Congress™ 2018 (ILC 2018), the 53rd annual meeting of the European Association for the Study of the Liver (EASL), the Home of Hepatology!
We are delighted to invite you to join the international liver community at the Paris expo Porte de Versailles – Pavillon 7, 1 Place de la Porte de Versailles, Paris, from 11 to 15 April 2018.
Hepatology is undergoing exciting changes – with highly effective drugs to cure hepatitis C, a dramatic increase of metabolic liver diseases and liver cancer worldwide, and a plethora of novel innovative treatment concepts from prevention, intervention to liver transplantation. It is our immense pleasure and honour to welcome you to ILC 2018, where we bring together clinicians, scientists and hepatology associates from all around the world to discuss latest advances at the frontline of hepatology.
Emerging areas are already visible in the 2018 ILC scientific programme, with multidisciplinary hepatology being a theme for both the postgraduate course and the newly established “Early morning rounds”. EASL’s partnerships with other major players in the field also have a strong standing in the 2018 edition of the ILC, with joint programming and totally new interactive formats like the Wednesday morning “Research think tanks”.
Other ILC highlights comprise:
- The postgraduate course on ‘viral hepatitis’
- State of the art lectures; “Is it time to abandon the diagnosis of cirrhosis?” and “Switching from homeostasis to disease: new therapeutic drug targets?”
- A basic science seminar on “Targetable pathways in liver disease”
- For the first time, a comprehensive transplant and surgery postgraduate course
- Over 1,500 original scientific projects presented – from almost 3,000 submitted abstracts
- Many interactive sessions: morning rounds, grand rounds, meet-the-expert workshops, and a comprehensive ‘skills in hepatology’ track
- EASL Clinical Practice Guidelines updates
- Collaborative sessions with multiple societies
- Complete tracks within all major topics of hepatology to keep you busy at all times – regardless of your specialty
- Public health and global hepatology (now comprehensively covered)
- Young investigator involvement.
Selected sessions and posters will be webcast and made available on the LiverTree™ for EASL members to view.
Despite all forms of digital communication, ILC 2018 provides a unique opportunity to discuss clinical innovation and research challenges but also to interact socially, network and develop future collaborations. Whether you are a young investigator, clinician, basic scientist, nurse, or a researcher, you will be exposed to the latest data in your specialty and can broaden your horizons in hepatology. Take part in an exciting week of liver discoveries and exchange by contributing on Twitter #ILC2018.
Thank you for believing in EASL and for your continued support and dedication to the field. We look forward to seeing you all in Paris at the 53rd Annual Congress, The International Liver Congress™ 2018.
Tom Hemming Karlsen Frank Tacke
EASL Secretary General EASL Vice-Secretary